Dr. Faithlore Gardner, MD
What this data tells you about Dr. Gardner
Dr. Faithlore Gardner is a hematology in Cape Coral, FL, with 18 years in practice. Based on federal Medicare data, Dr. Gardner performed 186,790 Medicare services across 4,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gardner received a total of $82,272 from 97 pharmaceutical and/or device companies across 1199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gardner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,570 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 24,000 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 21,210 | $6 | $23 |
| Daratumumab injection (Darzalex) | 15,840 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 15,780 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 11,100 | $18 | $51 |
| Iron sucrose injection (Venofer) | 9,100 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 8,190 | $1 | $5 |
| Injection, romiplostim, 10 micrograms | 3,745 | $73 | $197 |
| Immune globulin infusion (Gammagard) | 3,150 | $36 | $108 |
| Complete blood count (CBC) with differential | 2,982 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,743 | $0 | $3 |
| Blood draw (venipuncture) | 2,671 | $8 | $9 |
| Infliximab infusion (Remicade) | 1,670 | $26 | $124 |
| Injection, fulvestrant, 25 mg | 1,540 | $8 | $132 |
| Office visit, established patient (30-39 min) | 1,410 | $98 | $339 |
| Drug injection, under skin or into muscle | 1,254 | $11 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,070 | $1 | $28 |
| Administration of chemotherapy into vein, 1 hour or less | 548 | $102 | $378 |
| Injection of additional new drug or substance into vein | 502 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 393 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 340 | $50 | $189 |
| Anti-nausea injection (ondansetron/Zofran) | 332 | $0 | $9 |
| Office visit, established patient (20-29 min) | 276 | $67 | $239 |
| Injection, zoledronic acid, 1 mg | 269 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 199 | $1 | $3 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 175 | $26 | $89 |
| Infusion into a vein for hydration, each additional hour | 163 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 161 | $22 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 161 | $17 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 156 | $57 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 136 | $23 | $84 |
| Infusion, normal saline solution , 1000 cc | 126 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 107 | $16 | $56 |
| Infusion into a vein for hydration, 31-60 minutes | 106 | $25 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 98 | $52 | $178 |
| Automated urinalysis | 86 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 78 | $142 | $474 |
| Injection of drug or substance into vein | 64 | $30 | $156 |
| Prothrombin time test (blood clotting) | 46 | $4 | $15 |
| New patient office visit (45-59 min) | 38 | $129 | $453 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 37 | $1 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 33 | $3 | $11 |
| Red blood count automated, with additional calculations | 30 | $5 | $20 |
| New patient office visit (30-44 min) | 25 | $92 | $298 |
| Drawing of blood for a medical problem | 23 | $68 | $277 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 22 | $16 | $56 |
| Initial hospital admission, moderate complexity | 12 | $107 | $377 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $30 | $115 |
| Red blood count, automated test | 11 | $4 | $10 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology in FL.
Geographic Context
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gardner is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (speaking/promotional, top 6%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gardner experienced with iron infusion (feraheme)?
Does Dr. Gardner receive payments from pharmaceutical companies?
How do Dr. Gardner's costs compare to other hematologys in Cape Coral?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology